http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2359850-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 |
| filingDate | 2006-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55f79bd09fa7d8498c3f9b36e5b651cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d712707acbfffa7d8cdb6dd78588da80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6447a3d6c5640b7b1aadbd6c104bd0e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c36165599c10debd6604a4f6c1e7de82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92d5e620c07c32b9ac85e2baa6f8bae2 |
| publicationDate | 2011-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2359850-T3 |
| titleOfInvention | PEPTIDES WITH AGONIST ACTIVITY OF THE NEUROPEPTIDE-2 RECEPTOR (Y2R). |
| abstract | A neuropeptide-2 receptor agonist of formula (I): where: Y-R1-R2-X-R3-R4-R5-R6-R7-R8-R9-R10-R11-R12-R13-R14-NH2 X is selected from the group consisting of N-piperazin-1-yl-4 (3H) -quinozolinone-3-acetic acid (Pqa), N (5-O-carboxymethyl) -serotonin (Cms), 4- (2- aminomethyl) -6-dibenzofuranpropanoic acid, 4- (1-piperidin-4-yl) -butanoic acid and 4- (2-aminoethyl) -1-carboxymethyl piperazine, Y is H, a substituted or unsubstituted alkyl, a substituted or unsubstituted lower alkyl substituted, a substituted or unsubstituted aryl, a substituted or unsubstituted alkoxy or a polyethylene glycol moiety, R1 is Ile, Ala, (D) Ile, N-methyl Ile, Aib, 1-1Aic, 2-2 Aic, Ach or Acp , R2 is Lys, Ala, (D) Lys, NMelys, Nle or (Lys-Gly), R3 is Arg, Ala, (D) Arg, N-methylArg, Phe, 3,4,5-TrifluoroPhe or 2,3 , 4,5,6- Pentafluoro Phe, R4 is His, Ala, (D) His, N-methyl His, 4-MeOApc, 3-Pal or 4-Pal, R5 is Tyr, Ala, (D) Tyr, N - methyl Tyr, Trp, Tic, Bip, Dip, (1) Nal, (2) Nal, 3,4,5- TrifluroPhe or 2,3,4,5,6 Pentafluoro Phe, R6 is Leu, Ala, (D) Leu or N-methyl Leu, R7 is Asn, Ala or (D) Asn, R8 is Leu, Ala, (D) Leu or N-methyl Leu, R9 is Val, Ala, (D ) Val or N-methyl Val, R10 is Thr, Ala or N-methyl Thr, R11 is Arg, (D) Arg or N-methyl Arg, R12 is Gln or Ala, R13 is Arg, (D) Arg or N- methyl Arg, and R14 is Tyr, (D) Tyr or N-methyl Tyr, or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2005-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 361.